Description The present invention relates to new application forms of synthetic BPC (Body Protection Compound) peptides comprising 8 to 15 amino acid residues with a molecular weight of 900 to 1,600 daltons, which have organo-protective activity, to processes for their preparation and their use in diagnosis and therapy
These represent out-of-pocket expenses
GHK-Cus target tissues for skin and hair benefits, the dermis, epidermis, and hair follicles, are directly accessible through the skin
The Lancet (2021) This Phase 2 dose-finding trial randomized adults with overweight or obesity without diabetes to cagrilintide at doses from 0.3 to 4.5 mg weekly, placebo, or liraglutide 3.0 mg daily as an active comparator across 57 sites in 10 countries
Reported purity: 99%
No, combining experimental peptides without medical supervision drastically increases the risk of side effects and serious immune reactions